DEPRESSIVE DISORDERS IN NEWLY DIAGNOSED TUBERCULOSIS PATIENTS
Keywords:
tuberculosis, chemotherapy, depressive disorders, healthy people, patientsAbstract
Relevance. The problem of tuberculosis as an infectious disease does not lose its relevance against the background of a widespread decrease in the incidence of tuberculosis. The results of the study indicate the development of borderline mental disorders in tuberculosis patients after diagnosis, the elimination of which contributes to improving the effectiveness of comprehensive TB treatment. Purpose of the research. In order to take into account the peculiarities of the psychoemotional background in newly diagnosed tuberculosis patients, ensure timely correction of the identified disorders and increase the role of this category of patients in the treatment regimen, we decided at the end of the second month of chemotherapy to assess the degree of presence and severity of depressive disorders before they undergo the next X-ray examination. Materials and methods. The study involved 120 patients with active tuberculosis. Of these, 78 are men and 42 are women. The control group consisted of relatively healthy people who underwent routine check-ups in polyclinics, namely 135 men and 45 women. The study was conducted using V.Zung's method of differential diagnosis of depressive states, adapted by T.I.Balashova. The study was conducted in outpatient and inpatient settings with the participation of depressed patients suffering from mental or organic diseases. Results.The majority of patients with newly diagnosed tuberculosis had no depressive disorders by the end of the second month of chemotherapy. Mild depression of neurotic origin occurs in 26,6% of patients, one in ten patients has a state of masked depression, and 1,6% of patients have true depression. Conclusions. Patients with tuberculosis in this study are more susceptible to mild depression than healthy people, who have less depressive reactions. Consequently, by the end of the second month of chemotherapy, patients with newly diagnosed tuberculosis may need specially organized psychological and, in some cases, medical care to eliminate depressive tendencies of varying degrees.
References
Диагностика здоровья. Психологический практикум / Под ред. Г.С. Никифорова. –СПб.: Речь, 2011. – 950 с.
Маматова Н. Т. и др. Влияние улучшения психического состояния на эффективность лечения женщин, больных туберкулезом органов дыхания //Science and Education. – 2023. – Т. 4. – №. 5. – С. 156-165.
Мордык А.В. Социальный статус пациентов противотуберкулезного диспансера и его влияние на отношение к лечению / А.В. Мордык, Л.В. Пузырева, Т.Г. Подкопаева // Социология медицины. – 2011. – №2. – С. 44-47.
Осадчий А.В. Социально-демографическая характеристика больных туберкулезом легких и внелегочных локализаций / А.В. Осадчий, Е.В. Кульчавеня, Т.А. Рейхруд, С.Л. Нарышкина, Е.В. Кожевникова, В.Т. Хомяков // Туберкулез и болезни легких. – 2015. – №2. – С. 46-49.
Стрельцова Е.Н. Приверженность к лечению у впервые выявленных больных туберкулезом легких / Е.Н. Стрельцова, Н.А. Степанова, Д.А. Курамшин, Е.Б. Вирина // Астраханский медицинский журнал. – 2013. – Т. 8. – №3. – С. 130-132.
Хьелл Л., Зиглер Д. Теории личности. СПб.: Питер; 2014.
Abduhakimov B.A. Peculiarities of the course of pulmonary tuberculosis in children in combination with clay invasion. Journal of cardiorespiratory research. 2021, vol. 2, issue 1, pp.74-77.
Ataxanovna, K.S. The Effectiveness of Short-Term Treatment Regimens In The Treatment Of Drug-Resistant Forms Of Tuberculosis. European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 5236-5240.
Mamatova N. T. et al. The role of compliance in the treatment of tuberculosis patients //Science and Education. – 2024. – Т. 5. – №. 9. – С. 119-126.
Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry. 2011;168(6):603-9.
Fusar-Poli P, Kempton M, Rosenheck RA. Efficacy and safety of secondgeneration long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials. Int Clin Psychopharmacol. 2013;28(2):57-66.
